RHOA and COVID-19: We hypothesized that SARS-CoV-2 infection impairs non-endothelium-dependent vasorelaxation pathways through VSMC and RhoA/Rho-kinase activation, which, together with altered calcium ion (Ca2+) handling in these cells, impairs vascular function in patients with post-COVID-19 conditions, compared with matched controls.